Add to ORKGCinacalcet is an effective treatment for secondary hyperparathyroidism in patients on dialysis. Until now, no randomized, placebo-controlled, long-term trial has tested this drug in individuals with chronic kidney disease who are not receiving dialysisCKD-MBD experimental and epidemiological studies have received support from FICYT (IB05-060), ISCIII-Retics-RD06, REDinREN (16/06), Fundación Renal Iñigo Alvarez de Toledo, Amgen, and Freseniu
Cinacalcet has proven effective in the treatment of secondary hyperparathyroidism (SHPT) in dialysis...
Cinacalcet HCl: A novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney diseas...
With the aim to expand the randomized controlled trial evidence of cinacalcet treatment to the unsel...
Cinacalcet is an effective treatment for secondary hyperparathyroidism in patients on dialysis. Unti...
Background Secondary hyperparathyroidism (SHPT) is a common complication in chronic kidney disease (...
The effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary hyperparathyroidi...
Background: secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease ...
AbstractBackgroundThe effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary...
Introduction Secondary hyperparathyroidism (SHPT) develops in patients with chronic renal failure. C...
BACKGROUND: Disorders of mineral metabolism, including secondary hyperparathyroidism, are thought ...
BACKGROUND: Disorders of mineral metabolism, including secondary hyperparathyroidism, are thought to...
Introduction — Secondary hyperparathyroidism (SHPT) is common in patients with chronic kidney diseas...
BACKGROUND: Treatment of secondary hyperparathyroidism with vitamin D and calcium in patients rece...
Cinacalcet lowers parathyroid hormone levels. Whether it can prolong survival of people with chronic...
Background: Secondary hyperparathyroidism (SHPT) is associated with high incidences of cardiovascula...
Cinacalcet has proven effective in the treatment of secondary hyperparathyroidism (SHPT) in dialysis...
Cinacalcet HCl: A novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney diseas...
With the aim to expand the randomized controlled trial evidence of cinacalcet treatment to the unsel...
Cinacalcet is an effective treatment for secondary hyperparathyroidism in patients on dialysis. Unti...
Background Secondary hyperparathyroidism (SHPT) is a common complication in chronic kidney disease (...
The effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary hyperparathyroidi...
Background: secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease ...
AbstractBackgroundThe effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary...
Introduction Secondary hyperparathyroidism (SHPT) develops in patients with chronic renal failure. C...
BACKGROUND: Disorders of mineral metabolism, including secondary hyperparathyroidism, are thought ...
BACKGROUND: Disorders of mineral metabolism, including secondary hyperparathyroidism, are thought to...
Introduction — Secondary hyperparathyroidism (SHPT) is common in patients with chronic kidney diseas...
BACKGROUND: Treatment of secondary hyperparathyroidism with vitamin D and calcium in patients rece...
Cinacalcet lowers parathyroid hormone levels. Whether it can prolong survival of people with chronic...
Background: Secondary hyperparathyroidism (SHPT) is associated with high incidences of cardiovascula...
Cinacalcet has proven effective in the treatment of secondary hyperparathyroidism (SHPT) in dialysis...
Cinacalcet HCl: A novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney diseas...
With the aim to expand the randomized controlled trial evidence of cinacalcet treatment to the unsel...